Cancer Test Market 2018 Global Key Players, Trends, Share, Industry Size, Key Developments, Opportun
Pune, India - October 30, 2018 /MarketersMedia/ — Global Cancer Test Market
This report focuses on the global Cancer Test status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Test development in United States, Europe and China.
Cancer is the second-leading cause of death and disability in the world, only behind heart disease. More people die from cancer around the world than AIDS, Tuberculosis and Malaria combined every year.
According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-based, private practice oncology settings. Therefore, global expansion of cancer marker technologies may be fueled by an increased marketing of new diagnostic tests to physicians.
Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3339064-global-cancer-test-market-size-status-and-forecast-2018-2025
The key players covered in this study
Abbott
Radient Pharmaceuticals
BD Diagnostics
Beckman Coulter
BioCurex
bioMerieux
Cepheid
CytoCore
DiagnoCure
Gen-Probe
Genomic Health
QIAGEN Marseille (Earlier Ipsogen)
Myriad Genetics
Panacea Pharmaceuticals
Qiagen
Siemens Heathcare Diagnostics
Roche
Ventana Medical Systems
Trovagene
Vermillion
During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. The anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy.
In 2017, the global Cancer Test market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
Market segment by Type, the product can be split into
Laboratory Tests
Genetic Tests
Imaging
Endoscopy
Market segment by Application, split into
Bladder Cancer Test
Breast Cancer Test
Cervical Cancer Test
Colorectal (Colon) Cancer Test
Ovarian Cancer Test
Prostate Cancer Test
Liver Cancer Test
Flow Cytometry
Other Organ Specific Cancer Test
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cancer Test status, future forecast, growth opportunity, key market and key players.
To present the Cancer Test development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
Table of Contents-Key Points Covered
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Test Market Size Growth Rate by Type (2013-2025)
1.4.2 Laboratory Tests
1.4.3 Genetic Tests
1.4.4 Imaging
1.4.5 Endoscopy
1.5 Market by Application
1.5.1 Global Cancer Test Market Share by Application (2013-2025)
1.5.2 Bladder Cancer Test
1.5.3 Breast Cancer Test
1.5.4 Cervical Cancer Test
1.5.5 Colorectal (Colon) Cancer Test
1.5.6 Ovarian Cancer Test
1.5.7 Prostate Cancer Test
1.5.8 Liver Cancer Test
1.5.9 Flow Cytometry
1.5.10 Other Organ Specific Cancer Test
1.6 Study Objectives
1.7 Years Considered
………
Paid Portal PR Link :
12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Test Introduction
12.1.4 Abbott Revenue in Cancer Test Business (2013-2018)
12.1.5 Abbott Recent Development
12.2 Radient Pharmaceuticals
12.2.1 Radient Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Test Introduction
12.2.4 Radient Pharmaceuticals Revenue in Cancer Test Business (2013-2018)
12.2.5 Radient Pharmaceuticals Recent Development
12.3 BD Diagnostics
12.3.1 BD Diagnostics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Test Introduction
12.3.4 BD Diagnostics Revenue in Cancer Test Business (2013-2018)
12.3.5 BD Diagnostics Recent Development
12.4 Beckman Coulter
12.4.1 Beckman Coulter Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Test Introduction
12.4.4 Beckman Coulter Revenue in Cancer Test Business (2013-2018)
12.4.5 Beckman Coulter Recent Development
12.5 BioCurex
12.5.1 BioCurex Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Test Introduction
12.5.4 BioCurex Revenue in Cancer Test Business (2013-2018)
12.5.5 BioCurex Recent Development
12.6 bioMerieux
12.6.1 bioMerieux Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Test Introduction
12.6.4 bioMerieux Revenue in Cancer Test Business (2013-2018)
12.6.5 bioMerieux Recent Development
12.7 Cepheid
12.7.1 Cepheid Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Test Introduction
12.7.4 Cepheid Revenue in Cancer Test Business (2013-2018)
12.7.5 Cepheid Recent Development
12.8 CytoCore
12.8.1 CytoCore Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Test Introduction
12.8.4 CytoCore Revenue in Cancer Test Business (2013-2018)
12.8.5 CytoCore Recent Development
12.9 DiagnoCure
12.9.1 DiagnoCure Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Test Introduction
12.9.4 DiagnoCure Revenue in Cancer Test Business (2013-2018)
12.9.5 DiagnoCure Recent Development
12.10 Gen-Probe
12.10.1 Gen-Probe Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cancer Test Introduction
12.10.4 Gen-Probe Revenue in Cancer Test Business (2013-2018)
12.10.5 Gen-Probe Recent Development
12.11 Genomic Health
12.12 QIAGEN Marseille (Earlier Ipsogen)
12.13 Myriad Genetics
12.14 Panacea Pharmaceuticals
12.15 Qiagen
12.16 Siemens Heathcare Diagnostics
12.17 Roche
12.18 Ventana Medical Systems
12.19 Trovagene
12.20 Vermillion
Continued….
Complete Report Details @ https://www.wiseguyreports.com/reports/3339064-global-cancer-test-market-size-status-and-forecast-2018-2025
Contact Info:
Name: Norah Trent
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers, Magarpatta Road, Hadapsar,
Phone: +1 (339) 368 6938 (US) +44 208 133 9349 (UK)
Website: https://www.wiseguyreports.com
Replies